Dispatch From the DEA: DOI and DOC on Trial As Scientists Challenge Psychedelic Scheduling Bid

Coverage by Jack Gorsline in Arlington, Virginia, and Josh Hardman in London. In a quiet courtroom housed on the second floor of the Drug Enforcement Agency’s (DEA) Museum and Visitors Center in Arlington, Virginia, a legal battle is unfolding over the status of two key psychedelic research chemicals: 2,5-Dimethoxy-4-iodoamphetamine (DOI) and 2,5…

Source